Weekly Report
·
Strategic Signals Weekly
Licensing deals, strategic reviews, and financing events from SEC 8-K filings.
16
Total Signals
1
Licensing Deals
1
Strategic Reviews
13
Financing Events
Weekly Signal Volume
Licensing
Strategic
Financing
This week
Strategic Reviews
Companies exploring strategic alternatives, potential M&A, or board-level reviews.
| Company | Date | Details |
|---|---|---|
| Genprex, Inc. (GNPX) | Feb 23, 2026 | ...prioritization initiatives, and any other strategic alternatives or other efforts that Genprex takes or may take in the future that are aimed at optimizing and re-focusing Genprex's diabetes, oncology and/or other clinical development programs including... [SEC] |
Licensing & Partnerships
New collaboration agreements, licensing deals, and partnership announcements.
| Company | Date | Details |
|---|---|---|
| Theriva Biologics, Inc. (TOVX) | Feb 18, 2026 | ...(the "Company") entered into a license agreement (the "Agreement") with Rasayana Therapeutics, Inc. ("Rasayana"), whereby the Company granted Rasayana an exclusive worldwide license with the right to grant sublicenses to Research, Develop,... [SEC] |
Financing Events
Capital raises, ATM programs, debt offerings, and other financing activities.
| Company | Amount |
|---|---|
| Candel Therapeutics, Inc. (CADL) | $93.5M public offering [SEC] |
| ADC Therapeutics SA (ADCT) | public offering [SEC] |
| ATOSSA THERAPEUTICS, INC. (ATOS) | atm [SEC] |
| ORAMED PHARMACEUTICALS INC. (ORMP) | private placement [SEC] |
| COMPASS Pathways plc (CMPS) | $150.0M public offering [SEC] |
| HCW Biologics Inc. (HCWB) | $1.5M public offering [SEC] |
| PULSE BIOSCIENCES, INC. (PLSE) | atm [SEC] |
| AMGEN INC (AMGN) | $3,961.5M debt offering [SEC] |
| Opus Genetics, Inc. (IRD) | private placement [SEC] |
| Cingulate Inc. (CING) | $5.5M private placement [SEC] |
About This Data
Strategic signals are extracted from SEC 8-K filings using keyword analysis. We identify three categories:
- Strategic Reviews: Companies exploring "strategic alternatives," potential sales, or board-level reviews
- Licensing Deals: Collaboration agreements, licensing arrangements, and partnership announcements
- Financing Events: Capital raises, ATM offerings, debt issuances, and other financing activities
Data from RxDataLab and the SEC.